XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
  Hemorrhagic Fevers
  Avian Influenza
  Cholera
  Poliomyelitis
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Avian Influenza Channel
subscribe to Avian Influenza newsletter

World News : Epidemics : Avian Influenza

   DISCUSS   |   EMAIL   |   PRINT
Chemotherapy may help bird flu victims
Mar 3, 2006, 12:43, Reviewed by: Dr. Priya Saxena

"Etoposide is an excellent trigger of programmed cell death in immune cells,"

 
Chemotherapy for an immune system disorder might also be effective in treating people infected with the H5N1 strain of bird flu, scientists say.

With the possibility of resistance to antiviral treatments, absence of human vaccines and the spread of this flu across the globe, new treatments are urgently required, argues a team from the Karolinska University Hospital in Stockholm.

Jan-Inge Henter, a paediatric clinical oncologist, noticed that the symptoms of patients infected with H5N1 were very similar to those with an often-fatal immune disease called haemophagocytic lymphohitiocytosis (HLH), NewScientist.com reported.

Indeed, three papers on patients with H5N1 note that its symptoms include a profound over-response of the immune system, which also occurs in HLH patients.

The over-production of certain immune messengers, such as interleukin 6, is seen in H5N1 patients and cause of death is often linked to sepsis with multi-organ failure - all symptoms also associated with HLH.

But HLH, both in its inherited form and in response to the Epstein-Barr virus, can be treated with drugs, including a key chemotherapy called etoposide, which kills excess immune cells.

When the chemotherapy is given immediately, the treatments increased survival rates from 56 percent to 90 percent in comparison with giving treatment at four weeks or not at all, according to one retrospective study of patients with Epstein-Barr-virus-associated HLH.

"Etoposide is an excellent trigger of programmed cell death in immune cells," says Henter.

"So we think that the immune regulation of patients with severe (H5N1) infection is out of control. We are down-regulating things to kill off some of the cells to get some kind of balance - there is some logic to how this could work."
 

- Indo-Asian News Service
 

 
Subscribe to Avian Influenza Newsletter
E-mail Address:

 



Related Avian Influenza News

Are Flu Vaccines Worth the Effort?
Lessons from SARS may help prepare for bird flu
Incomplete vaccination could worsen the spread of avian flu
Scientists aim to thwart use of flu as bioweapon
Pakistani poultry industry demands 10-year tax holiday
Pandemic prevention plan approved for Asia Pacific
H5N1 threat puts human flu back in spotlight
Bird flu hits ninth poultry farm in Pakistan
Conjunctivitis caused by H7 avian influenza in a UK poultry worker
Bird flu strain makes Britain slaughter chicken


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us